About Company:
• The industry faces varied challenges, including adverse event (AE) volume management, complying with evolving regulations, and associated implementations while rationalizing costs. Besides, developing novel drugs such as monoclonal antibodies (mAbs), RNA vaccines, and combination products calls for high safety scrutiny.
• Increased awareness and knowledge are needed to evaluate real-world evidence (RWE) sources for signals and safety information. From a tools and technology perspective, the challenge is finding efficient and cost-effective cognitive solutions.
• Pharma companies have often expressed the need for scalable and flexible PV operations, harmonized global and local PV functions, breaking down silos between systems and processes, and resolving data interoperability issues.
• Focus on patient centricity, increased regulatory scrutiny, the emergence of complex diseases, and the need for next gen-treatment methodologies, are some of the key trends the pharmacovigilance (PV) space is witnessing.
• Pharma companies must focus on harmonizing global and local PV functions, addressing interoperability issues, and rationalizing siloed processes.
• We identify and implement continuous improvements and develop efficient, scalable, and cost-effective strategies.
Vacancy Details:
Job Description:
TCS Life Sciences Interview Drive – B-Pharma Graduates (2025)
TCS is hiring B-Pharma (2025) graduates for exciting opportunities in the Life Sciences domain!
Venue: Anjuman-I-Islam’s Kalsekar Technical Campus, Navi Mumbai
Date & Time: 19th March 2025 & 10 AM – 12 PM
Job Roles:
1. Clinical Data
2. Regulatory Affairs
3. Clinical Operations
4. Pharmacovigilance
Eligibility Criteria:
1. Full-time B-Pharma graduates (Year of Passing: 2025)
2. Open to work in all shifts
3. vancany for Mumbai location
Documents to Carry:
1. 1 Passport-size photo
2. Updated Resume
3. 1 Aadhar Card copy
Register under the BPS category to be considered: TCS NextStep
Start your journey with TCS Life Sciences – Don’t miss this opportunity!
For More Details Please fallow the below Image
